SELECT LANGUAGE BELOW

Mounjaro and Zepbound no longer in shortage

About two years later, federal regulators announced that the shortage of active ingredients in Mounjaro and Zepbound had been resolved. Tirzepatide, the active ingredient in diabetes and obesity drugs Mounjaro and Zepbound, was declared in short supply in December 2022. The cause of the shortage is believed to be increased demand due to increased interest […]